Partial Meal Replacement and Inulin in Obese Women
NCT01505023 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 179
Last updated 2012-01-06
Summary
The objective of this study was to test the efficacy of a partial meal replacement added with vitamins, minerals and inulin on weight reduction, blood lipids and micronutrients intake in obese Mexican women
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Partial meal replacement
The PMR was designed to contain sufficient amounts of all vitamins and minerals. Women were instructed to consume 2 servings per day at breakfast and dinner, each consisting of 33 g of powder dissolved in 250 ml of skim milk.
- DIETARY_SUPPLEMENT
-
Partial meal replacement with inulin
The PMR was designed to contain sufficient amounts of all vitamins and minerals plus inulin. Women were instructed to consume 2 servings per day at breakfast and dinner, each consisting of 33 g of powder dissolved in 250 ml of skim milk.
- DIETARY_SUPPLEMENT
-
Inulin
Women were asked to consume one 5g serving of inulin mixed with any drink at breakfast and same amount at dinner (10 g of inulin/d).
Sponsors & Collaborators
-
Nucitec SA de CV
collaborator UNKNOWN -
Cindetec
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-04-30
- Primary Completion
- 2006-11-30
- Completion
- 2007-02-28
Countries
- Mexico
Study Locations
More Related Trials
-
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
NCT07055516 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
NCT05110846 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
NCT00189514 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Zenoctil in Reducing Body Weight
NCT01423617 ·Status: COMPLETED ·Phase: PHASE3
-
This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity
NCT06857617 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
NCT03661879 ·Status: COMPLETED ·Phase: PHASE1
-
A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)
NCT00092872 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Gelesis200 on Appetite Parameters, Food Intake, and Glycemic Control in Overweight or Obese Prediabetic Subjects: A Sub-Study of LIGHT-UP
NCT03622424 ·Status: COMPLETED ·Phase: NA
-
A Trial to Assess Gastrointestinal Responses to Dietary Fibers in Adults Using Weight Loss Medications
NCT07012317 ·Status: COMPLETED ·Phase: NA
-
Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2).
NCT07165431 ·Status: RECRUITING ·Phase: NA
-
Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes
NCT02307279 ·Status: COMPLETED ·Phase: NA
-
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
NCT07184632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)
NCT04897412 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Pharmacotherapy With GLP-1 and GIP/GLP-1 Analogs on Changes in Qualitative and Quantitative Parameters of the Diet as Well as Metabolic and Behavioral Parameters in Patients With Excess Body Weight
NCT07270497 ·Status: RECRUITING
-
Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity
NCT03308721 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Patients Being Treated With Anti-obesity Medication
NCT06790160 ·Status: RECRUITING
-
Safety and Efficacy of IQP-AK-102 in Reducing Appetite
NCT02041754 ·Status: COMPLETED ·Phase: PHASE3
-
Stable Isotopes- Adults With Obesity
NCT07020741 ·Status: RECRUITING ·Phase: NA
-
Impact of Satiating Compounds and Hypocaloric Diet on Weight, Cardiometabolic and Osteoarticular Health in Obesity
NCT07165548 ·Status: RECRUITING ·Phase: NA
-
Evaluation of SODB® in Metabolic Adaptations in Overweight Women
NCT02667691 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
NCT05736107 ·Status: COMPLETED ·Phase: PHASE2
-
Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DM
NCT01648153 ·Status: COMPLETED ·Phase: PHASE2
-
DBRPC Study to Evaluate the Efficacy and Safety of IQP-AE-103 in Overweight and Moderately Obese Subjects
NCT04086797 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese Patients
NCT00622765 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
NCT06500429 ·Status: COMPLETED ·Phase: PHASE2